Alger Health Sciences Fund Class A (AHSAX) Fund Details & Analysis

Fund Information

Fund Category Health

Fund Family Alger

Fund Style Large

ISIN US0155657655

CUSIP 015565765

Inception Date 2002-05-01

Domicile United States

Country USA

Fiscal Year End October

NAV Chart

Fund Metrics

Net Assets $65.99 Million

Share Class Net Assets $46.19 Million

Expense Ratio 1.18%

Expense Ratio Date 2025-02-28

Dividend Yield 0.00%

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Performance

YTD Return 2.19%

1-Year Return 11.27%

3-Year Return 3.18%

5-Year Return -2.52%

NAV $23.30

Previous Close Price $23.44

Last Update 2025-12-31

Dividend Information

Dividend Yield 0.00%

Dividend (ttm) 0.17

Dividend Growth -58.12%

Payout Frequency Annual

Ex-Dividend Date n/a

Ratings

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Beta (5Y) 1.23

About Alger Health Sciences Fund Class A

The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can invest in foreign securities.

Detailed Metrics

Market Cap Distribution

AverageMarketCap 17210.87%

Giant 10.61%

Large 18.84%

Medium 22.35%

Micro 15.95%

Small 23.92%

Value & Growth Metrics

Book-Value Growth % -21.12%

Cash-Flow Growth % -17.74%

Dividend Yield % 0.73%

Historical Earnings % 9.87%

Long-Term Earnings % 12.11%

Asset Allocation

Type	Net %	Long %	Short %	Category Average	benchmark
Bond	0.00%	0.00%	0.00%	0.18%	0.00%
Cash	0.76%	0.76%	0.00%	1.44%	0.00%
Non US Stock	94.75%	94.75%	0.00%	8.38%	0.23%
Not Classified	0.00%	0.00%	0.00%	0.00%	0.00%
Other	4.49%	4.49%	0.00%	0.14%	0.00%
US Stock	0.00%	0.00%	0.00%	90.06%	99.77%

Top Holdings

Name	Weight	Owned	Change
UnitedHealth Group Inc	8.06%	-	-
Amgen Inc	4.08%	-	-
AstraZeneca PLC	None	-	-
AbbVie Inc	2.83%	-	-
McKesson Corp	3.47%	-	-
Regeneron Pharmaceuticals Inc	None	-	-
Eli Lilly Co	3.22%	-	-
Merck Co Inc	None	-	-
Vertex Pharmaceuticals Inc	None	-	-
ICON PLC	None	-	-
Intuitive Surgical Inc	5.06%	-	-
Boston Scientific Corp	3.05%	-	-
IMPULSE DYNAMICS IRELAND	4.34%	-	-
Illumina Inc	4.30%	-	-
Welltower Inc	4.32%	-	-
Bristol-Myers Squibb Co	3.66%	-	-
Stryker Corp	4.03%	-	-
Sandoz Group AG	4.63%	-	-
Masimo Corp	4.04%	-	-
Cardinal Health Inc	4.04%	-	-
Abbott Laboratories	5.20%	-	-
Waystar Holding Corp	4.93%	-	-
Dreyfus Treasury Obligations Cash Management Fund	4.44%	-	-
Royalty Pharma PLC	4.03%	-	-
American Healthcare REIT Inc	3.38%	-	-
Gilead Sciences Inc	3.10%	-	-
CVS Health Corp	4.81%	-	-
Repligen Corp	4.01%	-	-
Nektar Therapeutics	3.34%	-	-
Cidara Therapeutics Inc	2.87%	-	-

See the full breakdown of AHSAX fund's asset allocation and top holdings .

Sector Weights

Category	Subcategory	Amount %	Category Avg	Stocks %	Benchmark
Bond Sector	Cash and Equivalents	0.00%	88.82%	0.00%	0.00%
Bond Sector	Corporate	0.00%	11.18%	0.00%	0.00%
Bond Sector	Derivative	0.00%	0.00%	0.00%	0.00%
Bond Sector	Government	0.00%	0.00%	0.00%	0.00%
Bond Sector	Municipal	0.00%	0.00%	0.00%	0.00%
Bond Sector	Securitized	0.00%	0.00%	0.00%	0.00%
Cyclical	Basic Materials	0.00%	0.00%	0.00%	0.00%
Cyclical	Consumer Cyclical	0.00%	0.00%	0.00%	0.00%
Cyclical	Financial Services	0.00%	0.02%	0.00%	0.00%
Cyclical	Real Estate	0.00%	0.14%	0.00%	0.00%
Defensive	Consumer Defensive	0.00%	0.00%	0.00%	0.00%
Defensive	Healthcare	0.00%	99.80%	0.00%	100.00%
Defensive	Utilities	0.00%	0.00%	0.00%	0.00%
Sensitive	Communication Services	0.00%	0.00%	0.00%	0.00%
Sensitive	Energy	0.00%	0.02%	0.00%	0.00%
Sensitive	Industrials	0.00%	0.01%	0.00%	0.00%
Sensitive	Technology	0.00%	0.00%	0.00%	0.00%

World Regions

Region	Subregion	Category Average	Stocks Percent	Benchmark
Americas	Latin America	-	-	-
Americas	North America	91.79%	82.99%	99.77%
Greater Asia	Asia Developed	0.09%	-	-
Greater Asia	Asia Emerging	0.10%	2.62%	-
Greater Asia	Australasia	0.07%	-	-
Greater Asia	Japan	0.40%	-	-
Greater Europe	Africa/Middle East	0.26%	1.86%	-
Greater Europe	Europe Developed	5.28%	9.95%	0.10%
Greater Europe	Europe Emerging	-	-	-
Greater Europe	United Kingdom	2.01%	2.58%	0.13%

Dividend History

Date	Amount	Unadjusted Amount	Currency	Declaration Date	Record Date	Payment Date	Period
2021-12-15	$0.000	$0.000	None	-	-	-	-
2020-12-16	$0.000	$0.000	None	-	-	-	-
2019-12-18	$0.000	$0.000	None	-	-	-	-
2018-12-18	$0.000	$0.000	None	-	-	-	-
2017-12-15	$0.000	$0.000	None	-	-	-	-
2015-12-16	$0.000	$0.000	None	-	-	-	-
2014-12-18	$0.158	$0.158	USD	-	-	-	-
2013-12-18	$0.000	$0.000	None	-	-	-	-
2012-12-18	$0.010	$0.010	USD	-	-	-	-
2010-04-30	$0.025	$0.025	USD	-	-	-	-
2007-12-18	$0.000	$0.000	None	-	-	-	-
2006-12-19	$0.000	$0.000	None	-	-	-	-
2005-12-20	$0.349	$0.349	USD	-	2005-12-19	2005-12-20	Other
2004-12-17	$0.000	$0.000	None	-	-	-	-
2003-12-19	$0.000	$0.000	None	-	-	-	-

Related Funds to Explore

Columbia Income Opportunities Fund Institutional 3 Class (CIOYX) fund overview	View NWHKX fund performance & NAV
SAMZX mutual fund analysis	Check WFATX expense ratio & ratings
American Century Core Plus Fund Class A fund metrics & details	Explore ADGCX investment profile
SDMGX fund yield & return data	Review Goldman Sachs Inflation Protected Securities Fund Class A Shares fund information
TMAFX morning star rating & risk analysis	Compare FZADX fund sector allocation
Brookfield Global Listed Infrastructure Fund Class A net assets & portfolio breakdown	Analyze VFWSX fund value & growth metrics
ADVKX asset allocation & world regions	Get Morgan Stanley Institutional Fund, Inc. International Equity Portfolio Class I (MSIQX) complete fund report

Alger Health Sciences Fund Class A NMFQS:AHSAX